Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 16/20 | 0.50 |
| ▸ | CTRC | Q99895 | 4/20 | 0.45 |
| ▸ | CMA1 | P23946 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710145 | 0.90 | ELANE (0.47) | ELANECTRCCMA1 | |
| SCHEMBL6707494 | 0.90 | ELANE (0.55) | ELANECTRCCMA1 | |
| SCHEMBL4350497 | 0.86 | CMA1 (0.44) | ELANECTRCCMA1 | |
| SCHEMBL31419970 | 0.86 | CMA1 (0.44) | ELANECTRCCMA1 | |
| SCHEMBL7951052 | 0.85 | CTRC (0.47) | CTRCCMA1 | |
| SCHEMBL6706856 | 0.84 | CMA1 (0.58) | CTRCCMA1 | |
| SCHEMBL6752547 | 0.84 | ELANE (0.43) | ELANECTRCCMA1 | |
| SCHEMBL7961182 | 0.83 | CMA1 (0.46) | CTRCCMA1 | |
| Hydrochloric Acid SCHEMBL7566410 | 0.83 | CMA1 (0.57) | CTRCCMA1 | |
| SCHEMBL6708761 | 0.83 | CMA1 (0.46) | CTRCCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040019068-A1 | Novel remedies or preventives for angiostenosis | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2004-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019068-A1 | Novel remedies or preventives for angiostenosis | CMA1, ACE, AGTR1 | ELANE 256/4885CTRC 824/4885CMA1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.